news

Our latest
Press Releases & Updates

Latest press releases

RetinAI attends ARVO 2022

RetinAI will attend the ARVO 2022 Annual Meeting in Denver, Colorado, from May 1st to 4th at the Colorado Convention Center. RetinAI will showcase its innovative data management and AI analysis solutions to optimize and simplify clinical development workflows for stakeholders in pharma, research and clinics. ARVO attendees who visit RetinAI at Booth #3008 will benefit from learning and seeing live demos on RetinAI Discovery for clinical studies, Discovery UNITY and RetinAI's Disease Evaluation Apps.

RetinAI highlights Geographic Atrophy research with models available for analysis to enable the right decision sooner during clinical studies

RetinAI is pleased to share research findings from three published papers in Geographic Atrophy (GA). In collaboration with the Department of Ophthalmology at the University of Lausanne, Jules-Gonin Hospital, researchers at RetinAI developed a model for predicting atrophy risk in patients with non-exudative age-related macular degeneration (AMD).

RetinAI announces a collaboration with Isarna Therapeutics

RetinAI Medical AG announced a collaboration with Isarna Therapeutics under which RetinAI’s IT solutions and artificial intelligence tools, including RetinAI Discovery®, shall be employed to support The BETTER Study, an international clinical trial evaluating the efficacy of ISTH0036 for neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME).

RetinAI collaboration with Heidelberg Engineering gives customers access to RetinAI’s analysis models in OCT

Bern, Switzerland and Heidelberg, Germany – RetinAI Medical AG and Heidelberg Engineering have announced a collaboration which will enable Heidelberg Engineering’s customers to utilize RetinAI’s portfolio of artificial intelligence analysis tools in combination with high-quality OCT images. Thanks to cloud exchange and application marketplace technologies, SPECTRALIS® users will have the option of sending OCT volume scans for analysis using RetinAI’s tools in a convenient and secure manner.

Latest updates

RetinAI at MICCAI'18 Labels [SEPTEMBER’18]

RetinAI participated in this year's edition of the annual International Conference on Medical Image Computing & Computer Assisted (MICCAI) in Granada, Spain, held on September 16-20.This year was the first time we sponsored the Large-Scale Annotation of Biomedical data and Expert Label Synthesis (LABELS) workshop at the event, offering a price to the winner of the competition for the best paper: 'Deep Learning Retinal Vessel Segmentation From a Single Annotated Example: An Application of Cyclic Generative Adversarial Neural Networks' by Praneeth Sadda, John A. Onofrey, and Xenophon Papademetris.

RetinAI at the NVIDIA Inception Awards [SEPTEMBER’18]

RetinAI is honoured to be one of the 10 selected projects to attend the GTC Europe Inception Awards NVIDIA, taking place in Munich between 9-11th October 2018. Hundreds of applications, 70 teams in the pitching semi-finals and only 10 teams in the final. Next step will be to compete live at the GTC to get a chance to win $100.000 and a NVIDIA DGX Workstation!

18th Euretina Congress [SEPTEMBER’18]

Our team members travelled to the European Society of Retina Specialists (EURETINA) in Vienna, 20-23 September, to present our latest products to make eye hospitals more efficient using Artificial Intelligence (AI). Stay tuned if you want to learn more about how AI is going to change the life of many eye care professionals in the near future.

AGEFI - RetinAI [JULY'18]

RetinAI is honoured to appear in the first page of AGEFI this 5th of July! Another opportunity to highlight how advanced machine learning and artificial intelligence are changing the world of ophthalmic care for the benefit of the patient and healthcare systems worldwide.

Contact us for more informations! We are happy to hear from you!